Get the Stockscreener App
11.49
1.03%
-0.12
Alumis Inc stock is traded at $11.49, with a volume of 753.99K.
It is down -1.03% in the last 24 hours and up +119.27% over the past month.
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
See More
Previous Close:
$11.61
Open:
$11.57
24h Volume:
753.99K
Relative Volume:
0.84
Market Cap:
$1.20B
Revenue:
-
Net Income/Loss:
$-238.77M
P/E Ratio:
-0.4286
EPS:
-26.808
Net Cash Flow:
$-216.62M
1W Performance:
+3.33%
1M Performance:
+119.27%
6M Performance:
+261.32%
1Y Performance:
+31.62%
1-Day Range:
$11.13
$11.79
1-Week Range:
$10.51
$12.44
52-Week Range:
$2.7601
$12.44
Alumis Inc Stock (ALMS) Company Profile
Name
Alumis Inc
Sector
Industry
Phone
650-231-6625
Address
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Compare ALMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALMS
Alumis Inc
|
11.49 | 1.21B | 0 | -238.77M | -216.62M | -26.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-25 | Initiated | Wells Fargo | Overweight |
| Jun-10-25 | Resumed | Guggenheim | Buy |
| Jan-30-25 | Initiated | Oppenheimer | Outperform |
| Oct-31-24 | Initiated | Robert W. Baird | Outperform |
| Oct-17-24 | Initiated | H.C. Wainwright | Buy |
| Jul-23-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-23-24 | Initiated | Guggenheim | Buy |
| Jul-23-24 | Initiated | Leerink Partners | Outperform |
| Jul-23-24 | Initiated | Morgan Stanley | Overweight |
View All
Alumis Inc Stock (ALMS) Latest News
General Atlantic L.P. Makes New Investment in Alumis Inc. $ALMS - MarketBeat
Alumis (NASDAQ:ALMS) Stock Price Down 5.2%Here's Why - MarketBeat
Insider Stock Purchases: December 10, 2025 - Quiver Quantitative
Velan Capital Investment Management LP Takes Position in Alumis Inc. $ALMS - MarketBeat
Insider Buying: Alumis (NASDAQ:ALMS) Director Purchases 186,377 Shares of Stock - MarketBeat
Alumis Inc (ALMS) director Akkaraju buys shares worth $1.83 million - Investing.com
Alumis stock hits 52-week high at 11.3 USD By Investing.com - Investing.com Canada
Alumis stock hits 52-week high at 11.3 USD - Investing.com India
Assessing Alumis (ALMS) Valuation After Director Srinivas Akkaraju’s $2 Million Insider Share Purchase - simplywall.st
Can Alumis Stock Hold Up When Markets Turn? - Trefis
What Do Director Insider Buys Reveal About Alumis’ (ALMS) Long-Term Alignment With Shareholders? - simplywall.st
Alumis (NASDAQ:ALMS) Trading Up 11.8% Following Insider Buying Activity - MarketBeat
Aug PreEarnings: Can Alumis Inc stock continue upward trendJuly 2025 Price Swings & AI Powered Market Entry Strategies - moha.gov.vn
Alumis (NASDAQ:ALMS) Hits New 12-Month High on Analyst Upgrade - MarketBeat
Alumis (NASDAQ:ALMS) Rating Increased to Hold at Wall Street Zen - MarketBeat
Alumis (NASDAQ:ALMS) Raised to Hold at Wall Street Zen - MarketBeat
Alumis (NASDAQ:ALMS) Director Purchases $540,100.86 in Stock - MarketBeat
Insider Buying: Alumis (NASDAQ:ALMS) Director Acquires 100,000 Shares of Stock - MarketBeat
Insider Stock Purchases: December 05, 2025 - Quiver Quantitative
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
349,615 Shares in Alumis Inc. $ALMS Bought by Stonepine Capital Management LLC - MarketBeat
After losing 3.7% in the past year, Alumis Inc. (NASDAQ:ALMS) institutional owners must be relieved by the recent gain - simplywall.st
Can Alumis Inc. stock continue upward trend2025 Buyback Activity & Expert Approved Trade Ideas - Newser
Alumis Insider Bought Shares Worth $2,039,901, According to a Recent SEC Filing - marketscreener.com
Alumis Inc (ALMS) director Akkaraju buys shares worth $2m By Investing.com - Investing.com Canada
Alumis Inc (ALMS) director Akkaraju buys shares worth $2m - Investing.com India
Why Alumis Inc. stock is a must watch in 2025Gold Moves & High Accuracy Trade Alerts - Newser
ALMS SEC FilingsAlumis Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Alumis (NASDAQ:ALMS) Shares Gap Up on Insider Buying Activity - MarketBeat
Insider Buying: Alumis (NASDAQ:ALMS) Director Purchases 38,702 Shares of Stock - MarketBeat
Alumis (NASDAQ:ALMS) Director Buys $370,822.68 in Stock - MarketBeat
Srinivas Akkaraju Acquires 86,350 Shares of Alumis (NASDAQ:ALMS) Stock - MarketBeat
Alumis Insider Bought Shares Worth $1,310,677, According to a Recent SEC Filing - marketscreener.com
Alumis (ALMS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Director Makes Major Investment in Alumis Inc. Stock! - TipRanks
Street Watch: Is Alumis Inc stock dividend yield sustainableMarket Rally & Stepwise Entry and Exit Trade Signals - BỘ NỘI VỤ
Why Alumis Inc. stock remains on buy listsTrade Exit Summary & Real-Time Volume Analysis - BỘ NỘI VỤ
Alumis reports Q3 revenue $2.07M, consensus $3.14M - MSN
Alumis Inc. $ALMS Shares Purchased by Foresite Capital Management VI LLC - MarketBeat
Major Stakeholders Show Confidence in Alumis Inc. with Significant Stock Purchases! - TipRanks
Insider Buying: Alumis (NASDAQ:ALMS) Director Acquires 125,743 Shares of Stock - MarketBeat
Tananbaum James B. buys Alumis Inc (ALMS) stock worth $532924 By Investing.com - Investing.com Canada
Tananbaum James B. buys Alumis Inc (ALMS) stock worth $532924 - Investing.com
[Form 4] ALUMIS INC. Insider Trading Activity - Stock Titan
Alumis Insider Bought Shares Worth $532,925, According to a Recent SEC Filing - marketscreener.com
Owner Foresite Labs LLC Buys 72,212 ($532.9K) Of Alumis Inc [ALMS] - TradingView
Foresite Capital Management VI LLC's Strategic Acquisition of Al - GuruFocus
Director Makes a Bold Move with Major Stock Purchase in Alumis Inc. - TipRanks
Alumis director Akkaraju buys $905,349 in ALMS stock By Investing.com - Investing.com Canada
Alumis Inc Stock (ALMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alumis Inc Stock (ALMS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director |
Dec 03 '25 |
Buy |
7.75 |
100,000 |
775,000 |
1,012,849 |
| AKKARAJU SRINIVAS | Director |
Dec 02 '25 |
Buy |
7.55 |
96,000 |
724,800 |
912,849 |
| AKKARAJU SRINIVAS | Director |
Dec 04 '25 |
Buy |
8.18 |
66,027 |
540,101 |
1,078,876 |
| AKKARAJU SRINIVAS | Director |
Dec 01 '25 |
Buy |
7.46 |
86,350 |
644,171 |
816,849 |
| AKKARAJU SRINIVAS | Director |
Nov 26 '25 |
Buy |
7.64 |
48,537 |
370,823 |
691,797 |
| AKKARAJU SRINIVAS | Director |
Nov 28 '25 |
Buy |
7.64 |
38,702 |
295,683 |
730,499 |
| Foresite Capital Management VI | 10% Owner |
Nov 21 '25 |
Buy |
7.38 |
72,212 |
532,925 |
2,614,215 |
| Tananbaum James B. | Director |
Nov 21 '25 |
Buy |
7.38 |
72,212 |
532,925 |
2,614,215 |
| Foresite Labs, LLC | 10% Owner |
Nov 21 '25 |
Buy |
7.38 |
72,212 |
532,925 |
2,614,215 |
| AKKARAJU SRINIVAS | Director |
Nov 20 '25 |
Buy |
7.20 |
125,743 |
905,350 |
643,260 |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):